PHASE IV CLINICAL TRIALS
\fˈe͡ɪz ɹˌə͡ʊmən fˈɔː klˈɪnɪkə͡l tɹˈa͡ɪə͡lz], \fˈeɪz ɹˌəʊmən fˈɔː klˈɪnɪkəl tɹˈaɪəlz], \f_ˈeɪ_z ɹ_ˌəʊ_m_ə_n_ f_ˈɔː k_l_ˈɪ_n_ɪ_k_əl t_ɹ_ˈaɪ_əl_z]\
Definitions of PHASE IV CLINICAL TRIALS
Sort: Oldest first
-
sometimes the FDA approves a drug for general use but requires to manufacturer to continue to monitor its effects; during phase IV the drug may be tried on slightly different patient populations than those studied in earlier trials
By Princeton University
-
sometimes the FDA approves a drug for general use but requires to manufacturer to continue to monitor its effects; during phase IV the drug may be tried on slightly different patient populations than those studied in earlier trials
By DataStellar Co., Ltd
-
Planned post-marketing studies of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale. These studies are often conducted to obtain additional data about the safety and efficacy of a product. This concept includes phase IV studies conducted in both the U.S. and in other countries.
By DataStellar Co., Ltd
Word of the day
basidiomycota
- comprises fungi bearing the spores on basidium: Gasteromycetes (puffballs); Tiliomycetes (comprising orders Ustilaginales (smuts) and Uredinales (rusts)); Hymenomycetes (mushrooms; toadstools; agarics; bracket fungi); in some classification systems considered a division of kingdom comprises fungi bearing spores on a basidium; includes Gasteromycetes (puffballs) Tiliomycetes comprising the orders Ustilaginales (smuts) and Uredinales (rusts) Hymenomycetes (mushrooms, toadstools, agarics bracket fungi).